corydaline
Sign in to saveAlso known as (13S,13aR)-2,3,9,10-tetramethoxy-13-methyl-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline, (+)-Corydaline
Corydaline is an acetylcholinesterase inhibitor isolated from Corydalis yanhusuo.
Research
91 papers- Corydaline alleviates Parkinson's disease by regulating autophagy and GSK-3β phosphorylation.Psychopharmacology · 2024
- Corydaline binds to a druggable pocket of hEAG1 channel and inhibits hepatic carcinoma cell viability.European journal of pharmacology · 2024
- Corydaline inhibits enterovirus 71 replication by regulating COX-2 expression.Journal of Asian natural products research · 2017
- Corydaline attenuates osteolysis in rheumatoid arthritis via mitigating reactive oxygen species production and suppressing calcineurin-Nfatc1 signaling.International immunopharmacology · 2024
- Corydaline and l-tetrahydropalmatine attenuate morphine-induced conditioned place preference and the changes in dopamine D(2) and GluA1 AMPA receptor expression in rats.European journal of pharmacology · 2020
via PubMed
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Corydaline is an acetylcholinesterase inhibitor isolated from Corydalis yanhusuo.
Corydaline is a pharmacologically active isoquinoline alkaloid isolated from Corydalis tubers. It also has diverse biological activities. It exhibits the antiacetylcholinesterase(AChE; IC50 = 15 μM), antiallergic, antinociceptive, and gastric emptying activities.
Excerpted from Wikipedia’s “corydaline” article, available under the CC BY-SA 4.0 licence.